🕵️ Grace Therapeutics, Inc. ($GRCE)
SEC insider & ownership activity, last 12 months · CIK 1444192 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. No red-flag 8-Ks in the window.
Insider flow
2 buyers, value withheld pending verification (4 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Kohli Prashant | 1 | $214K | 0 | – | Sep 9, 2026 |
| Opaleye Management Inc. | 3 | value withheld pending verification | 0 | – | Sep 9, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 13.1% | 13G | Aug 7, 2026 | filing ↗ | |
| Opaleye, L.P. | 13.1% | 13G | Aug 7, 2026 | filing ↗ | |
| James Silverman | 13.1% | 13G | Aug 7, 2026 | filing ↗ | |
| Hirschman Orin | 9.9% | 13G | May 8, 2025 | filing ↗ | |
| AIGH Capital Management, LLC | 9.9% | 13G | May 8, 2025 | filing ↗ | |
| ADAR1 Capital Management, LLC | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Daniel Schneeberger | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| ADAR1 Capital Management GP, LLC | 8.6% | 13G | Aug 14, 2026 | filing ↗ | |
| Nantahala Capital Management, LLC | 6.8% | 13G | Aug 14, 2026 | filing ↗ | |
| Wilmot B. Harkey | 6.8% | 13G | Aug 14, 2026 | filing ↗ | |
| Daniel Mack | 6.8% | 13G | Aug 14, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2026 | filing ↗ |
| Material agreement (1.01) | Aug 4, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 4, 2026 | filing ↗ |
| Other events (8.01) | Aug 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 4, 2026 | filing ↗ |
| Other events (8.01) | Jul 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 28, 2026 | filing ↗ |
| Other events (8.01) | Jun 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 18, 2026 | filing ↗ |
| Earnings (2.02) | Jun 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 18, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 1, 2026 | filing ↗ |
| Other events (8.01) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Other events (8.01) | Apr 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 23, 2026 | filing ↗ |
| Earnings (2.02) | Feb 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 10, 2026 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Other events (8.01) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Other events (8.01) | Oct 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 23, 2025 | filing ↗ |
| Other events (8.01) | Sep 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 18, 2025 | filing ↗ |